Â¥
11.92
Jul 7
New Key Statistics Module, Z-Score and F-Score
SHSE:603707 Key Ratios
Market Cap ¥ M | 18,328.87 |
Enterprise Value ¥ M | 18,895.15 |
P/E(ttm) | -- |
PE Ratio without NRI | 25.09 |
Forward PE Ratio | -- |
Price/Book | 3.22 |
Price/Sales | 5.22 |
Price/Free Cash Flow | 15.03 |
Price/Owner Earnings | -- |
Payout Ratio % | 0.24 |
Revenue (TTM) ¥ M | 3,628.00 |
EPS (TTM) ¥ | -0.22 |
Beneish M-Score | -3.17 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -142.80 |
EV-to-EBIT | -47.95 |
EV-to-EBITDA | -47.95 |
PEG | -- |
Shares Outstanding M | 1,615.63 |
Net Margin (%) | -9.50 |
Operating Margin % | 20.57 |
Pre-tax Margin (%) | -13.12 |
Quick Ratio | 1.15 |
Current Ratio | 2.46 |
ROA % (ttm) | -3.31 |
ROE % (ttm) | -5.43 |
ROIC % (ttm) | 7.24 |
Dividend Yield % | 1.01 |
Altman Z-Score | 4.24 |
SHSE:603707 Number of Guru Trades
SHSE:603707 Volume of Guru Trades
Gurus Latest Trades with SHSE:603707
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
SHSE:603707 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nanjing King-Friend Biochemical Pharmaceutical Co Ltd Insider Transactions
No Available Data